Eric Sugar is the President and General Partner at Landmark Ventures, a position he has held since March 2023. Based in the United States, Eric has been with Landmark Ventures since 2006, initially joining as an Associate Partner. He was promoted to General Partner in January 2009, a role he held until his current appointment.

Prior to his tenure at Landmark Ventures, Eric served as a Science Advisor for Drug & Medical Devices at Weitz & Luxenberg from August 2005 to December 2006. He also worked as a Research Assistant at Washington University School of Medicine from January 2004 to January 2005 and was involved in Exploratory Research at Baxter Healthcare in 2003.

Eric's extensive experience in investment banking and advisory services has been instrumental in driving the strategic initiatives at Landmark Ventures.